Drugs / Weileshu
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04021589 | Jul 2019 → Oct 2021 | colorectal cancer | Zhejiang University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Weileshu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04021589 ↗ |
| Route | Oral | “additional oral administration of Weileshu, a probiotics product” NCT04021589 ↗ |